YCBD
Income statement / Annual
Last year (2024), cbdMD, Inc.'s total revenue was $19.48 M,
a decrease of 19.35% from the previous year.
In 2024, cbdMD, Inc.'s net income was -$3.70 M.
See cbdMD, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
| Operating Revenue |
$19.48 M |
$24.16 M |
$35.40 M |
$44.48 M |
$41.88 M |
$23.65 M |
$8.42 M |
$4.47 M |
$2.03 M |
| Cost of Revenue |
$7.49 M
|
$9.18 M
|
$13.07 M
|
$14.50 M
|
$15.51 M
|
$9.14 M
|
$2.67 M
|
$1.36 M
|
$1.62 M
|
| Gross Profit |
$12.00 M
|
$14.98 M
|
$22.34 M
|
$29.99 M
|
$26.37 M
|
$14.51 M
|
$5.75 M
|
$3.12 M
|
$413,130.00
|
| Gross Profit Ratio |
0.62
|
0.62
|
0.63
|
0.67
|
0.63
|
0.61
|
0.68
|
0.7
|
0.2
|
| Research and Development Expenses |
$39,021.00
|
$173,038.00
|
$633,392.00
|
$1.42 M
|
$424,450.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$8.44 M
|
$9.62 M
|
$15.81 M
|
$21.77 M
|
$23.06 M
|
$0.00
|
$1.79 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$4.18 M
|
$6.95 M
|
$15.44 M
|
$17.57 M
|
$11.84 M
|
$0.00
|
$143,701.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.62 M
|
$16.55 M
|
$31.25 M
|
$39.34 M
|
$34.90 M
|
$28.88 M
|
$1.93 M
|
$3.36 M
|
$0.00
|
| Other Expenses |
$2.65 M
|
$7.52 M
|
$7.67 M
|
$8.84 M
|
$9.05 M
|
$28.88 M
|
$5.63 M
|
$3.36 M
|
$4.15 M
|
| Operating Expenses |
$15.31 M
|
$24.25 M
|
$39.56 M
|
$49.60 M
|
$43.95 M
|
$28.88 M
|
$5.63 M
|
$3.36 M
|
$4.15 M
|
| Cost And Expenses |
$22.80 M
|
$33.42 M
|
$52.63 M
|
$64.10 M
|
$59.47 M
|
$38.01 M
|
$8.30 M
|
$4.71 M
|
$5.76 M
|
| Interest Income |
$0.00
|
$63,702.00
|
$16,246.00
|
$28,930.00
|
$39,877.00
|
$75,071.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$16,246.00
|
$28,930.00
|
$0.00
|
$0.00
|
$955.00
|
$500,627.00
|
$154,977.00
|
| Depreciation & Amortization |
$1.82 M
|
$2.93 M
|
$2.97 M
|
$2.25 M
|
$1.90 M
|
$289,574.00
|
$222,546.00
|
$71,276.00
|
$44,935.00
|
| EBITDA |
-$1.49 M |
-$7.47 M |
-$15.48 M |
-$22.01 M |
-$16.86 M |
-$14.09 M |
-$1.57 M |
-$789,265.00 |
-$3.69 M |
| EBITDA Ratio |
-0.08
|
-0.31
|
1.1
|
-0.29
|
-1.09
|
0.82
|
0.04
|
-0.14
|
-1.82
|
| Operating Income Ratio |
-0.17
|
-0.38
|
1.01
|
-0.44
|
-0.42
|
0.81
|
0.01
|
-0.05
|
-1.84
|
| Total Other Income/Expenses Net |
-$384,716.00
|
-$13.67 M
|
-$52.77 M
|
-$4.67 M
|
$28.89 M
|
-$32.99 M
|
$0.00
|
-$1.12 M
|
-$154,977.00
|
| Income Before Tax |
-$3.70 M
|
-$22.94 M
|
-$70.08 M
|
-$24.29 M
|
$11.31 M
|
-$47.79 M
|
$46,834.00
|
-$1.36 M
|
-$3.89 M
|
| Income Before Tax Ratio |
-0.19
|
-0.95
|
-1.98
|
-0.55
|
0.27
|
-2.02
|
0.01
|
-0.3
|
-1.91
|
| Income Tax Expense |
$0.00
|
$0.00
|
$4.00 M
|
-$895,000.00
|
-$1.35 M
|
-$2.36 M
|
-$16,000.00
|
$25,000.00
|
$8,000.00
|
| Net Income |
-$3.70 M
|
-$22.94 M
|
-$74.09 M
|
-$23.39 M
|
$12.60 M
|
-$45.43 M
|
-$412,075.00
|
-$1.74 M
|
-$3.36 M
|
| Net Income Ratio |
-0.19
|
-0.95
|
-2.09
|
-0.53
|
0.3
|
-1.92
|
-0.05
|
-0.39
|
-1.65
|
| EPS |
1.93 |
-13.32 |
-55.8 |
-19.16 |
12.47 |
-114.29 |
-2.39 |
-10.44 |
-36.58 |
| EPS Diluted |
1.93 |
-13.32 |
-55.8 |
-19.16 |
12.19 |
-114.29 |
-2.39 |
-10.44 |
-36.58 |
| Weighted Average Shares Out |
$4.31 M
|
$2.02 M
|
$1.33 M
|
$1.22 M
|
$980,896.00
|
$397,494.00
|
$172,058.00
|
$166,494.00
|
$91,745.00
|
| Weighted Average Shares Out Diluted |
$4.31 M
|
$2.02 M
|
$1.33 M
|
$1.22 M
|
$1.00 M
|
$397,494.00
|
$172,221.00
|
$166,494.00
|
$91,745.00
|
| Link |
|
|
|
|
|
|
|
|
|
